Enterprise Investors’ latest moves – from Eycore to its broader portfolio – illustrate how even traditional PE funds are now structurally dependent on tech-driven deals.
CEO Jarosław Parkot argues that current market dynamics in Poland’s motor insurance sector risk eroding industry-wide results and require a structural price adjustment.
Best known for its banana trading business, Citronex is investing hundreds of millions of złoty in greenhouse expansion and new agricultural segments, with bananas still generating the bulk of its revenue.
Pure Biologics’ PLN 50m capital raise marks more than a refinancing moment. Backed by Biofund and U.S.-based surgeon-entrepreneur Kris Siemionow, the Warsaw-listed company is betting on multiQure – a gene-silencing therapy for Huntington’s disease that could reshape its fortunes and position it against a $3 billion global competitor.
Leading Polish entrepreneurs are pushing for a structural shift in the country’s economic model, arguing that productivity, innovation, and state efficiency must replace labor-cost advantages as the main growth drivers.
Regulatory scrutiny, tensions with logistics partners, and fierce competition from Chinese platforms have not slowed Allegro’s expansion, says CEO Marcin Kuśmierz. Instead, he argues, they are accelerating the company’s transformation.
Poland could become the site of a Taiwanese-led technology park anchored by Foxconn, with potential investments reaching up to USD 20 billion as companies explore AI, electronics, and long-term semiconductor production in Europe.
Slower recruitment markets in Germany and a sharp reset in SaaS valuations have complicated Pracuj Group’s growth trajectory. Yet the Polish HR tech leader remains committed to its 2030 targets, relying on efficiency improvements and artificial intelligence rather than aggressive expansion.
Crowdfunding is emerging as a supplementary funding tool for property developers seeking flexibility alongside traditional bank loans and investment funds. But industry players stress that the sector will only grow if investors learn to assess risks and trust the new model.
Alab Laboratoria is expanding aggressively across Poland’s diagnostics sector. But its founder says the real constraint is not demand or technology - it is the difficulty of securing bank financing for growth.
Mariusz Bartodziej 
Piotr Sobolewski 
Magdalena Brzózka 
Cezary Szczepański 
Małgorzata Grzegorczyk 
Szymon Matuszyński 
